Abstract
Full text available
Current Alzheimer Research
Title: The Perils of Alzheimers Drug Development
Volume: 6 Issue: 1
Author(s): Lon S. Schneider and Debomoy K. Lahiri
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Schneider S. Lon and Lahiri K. Debomoy, The Perils of Alzheimers Drug Development, Current Alzheimer Research 2009; 6 (1) . https://dx.doi.org/10.2174/156720509787313871
DOI https://dx.doi.org/10.2174/156720509787313871 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MicroRNA Expression Analysis of Adult-Onset Drosophila Alzheimer`s Disease Model
Current Alzheimer Research Actions of Melatonin, Its Structural and Functional Analogs in the Central Nervous System and the Significance of Metabolism
Central Nervous System Agents in Medicinal Chemistry Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)
CNS & Neurological Disorders - Drug Targets BACE1 Structure and Function in Health and Alzheimers Disease
Current Alzheimer Research Biomarkers of Alzheimer’s Disease: An Overview of the Recent Inventions
Recent Patents on Biomarkers Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews Low Plasma Leptin in Cognitively Impaired ADNI Subjects: Gender Differences and Diagnostic and Therapeutic Potential
Current Alzheimer Research Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease
Current Alzheimer Research Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry The Cytokine Network in HIV Infection
Current Molecular Medicine Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design Metabolic and Cardiovascular Complications of Highly Active Antiretroviral Therapy for HIV Infection
Current HIV Research Fibrin Clot Properties and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Treatment of Fabry Disease: Current and Emerging Strategies
Current Pharmaceutical Biotechnology Systematic Review of Public Education and Policy for Stroke Prevention
Current Drug Targets The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member:
Recent Patents on Inflammation & Allergy Drug Discovery Anandamide Dysfunction in Prodromal and Established Psychosis
Current Pharmaceutical Design Effects of Mindfulness on Diabetes Mellitus: Rationale and Overview
Current Diabetes Reviews